Literature DB >> 8900088

Cytopathological findings on vaginal Papanicolaou smears after hysterectomy for benign gynecologic disease.

K F Pearce1, H K Haefner, S F Sarwar, T E Nolan.   

Abstract

BACKGROUND: Periodic, routine Papanicolaou smears of cells from the vagina are commonly examined in women who have undergone a hysterectomy for benign gynecologic disease. The benefits of this method of screening are not known.
METHODS: We analyzed Papanicolaou smears obtained from the vaginal apex (cuff) in 6265 women at Charity Hospital in New Orleans between January 1, 1992, and December 31, 1994. Of the 10,595 vaginal smears, an estimated 9610 were obtained during follow-up examinations of 5682 women who had undergone hysterectomy for benign gynecologic disease.
RESULTS: Among these 9610 vaginal smears, 104, from 79 women, were abnormal. The abnormal smears were categorized according to the findings, as follows: atypical squamous cells of undetermined significance, 52 (0.5 percent of all smears); low-grade squamous intraepithelial lesion, 44 (0.5 percent); high-grade squamous intraepithelial lesion, 6 (0.1 percent); and squamous-cell carcinoma, 2 (0.02 percent). In five women, biopsies revealed vaginal intraepithelial neoplasia type I or II; there were no biopsy-proved cases of vaginal cancer. The probability of an abnormal Papanicolaou smear in this group of women was 1.1 percent, and the positive predictive value of the Papanicolaou test for detecting vaginal cancer was 0 percent (95 percent confidence interval, 0 to 33 percent).
CONCLUSIONS: The prevalence of abnormal findings on cytopathological examination of vaginal Papanicolaou smears after hysterectomy for benign gynecologic disease is extremely low.

Entities:  

Mesh:

Year:  1996        PMID: 8900088     DOI: 10.1056/NEJM199611213352103

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  12 in total

Review 1.  A common clinical dilemma: Management of abnormal vaginal cytology and human papillomavirus test results.

Authors:  Michelle J Khan; L Stewart Massad; Walter Kinney; Michael A Gold; E J Mayeaux; Teresa M Darragh; Philip E Castle; David Chelmow; Herschel W Lawson; Warner K Huh
Journal:  Gynecol Oncol       Date:  2016-02-22       Impact factor: 5.482

Review 2.  Cervical cancer: developments in screening and evaluation of the abnormal Pap smear.

Authors:  J M Walsh
Journal:  West J Med       Date:  1998-11

Review 3.  Recent advances. General medicine.

Authors:  L A Petersen
Journal:  BMJ       Date:  1998-09-19

4.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Authors:  Debbie Saslow; Diane Solomon; Herschel W Lawson; Maureen Killackey; Shalini L Kulasingam; Joanna Cain; Francisco A R Garcia; Ann T Moriarty; Alan G Waxman; David C Wilbur; Nicolas Wentzensen; Levi S Downs; Mark Spitzer; Anna-Barbara Moscicki; Eduardo L Franco; Mark H Stoler; Mark Schiffman; Philip E Castle; Evan R Myers
Journal:  CA Cancer J Clin       Date:  2012-03-14       Impact factor: 508.702

5.  Making Sense of Cervical Cancer Screening Guidelines and Recommendations.

Authors:  Michelle Davis; Sarah Feldman
Journal:  Curr Treat Options Oncol       Date:  2015-12

6.  Incidence and cytomorphological peculiarities of lower genital tract infections in vault (post hysterectomy) smears versus pap smears from non-hysterectomy subjects: a retrospective study.

Authors:  Veena Kashyap; Suresh Bhambhani
Journal:  J Obstet Gynaecol India       Date:  2011-10-29

7.  Improving Knowledge and Awareness of Human Papillomavirus-Associated Gynecologic Cancers: Results from the National Comprehensive Cancer Control Program/Inside Knowledge Collaboration.

Authors:  Julie S Townsend; Mary Puckett; Cynthia A Gelb; Martin Whiteside; Julia Thorsness; Sherri L Stewart
Journal:  J Womens Health (Larchmt)       Date:  2018-08       Impact factor: 2.681

Review 8.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Authors:  Debbie Saslow; Diane Solomon; Herschel W Lawson; Maureen Killackey; Shalini L Kulasingam; Joanna M Cain; Francisco A R Garcia; Ann T Moriarty; Alan G Waxman; David C Wilbur; Nicolas Wentzensen; Levi S Downs; Mark Spitzer; Anna-Barbara Moscicki; Eduardo L Franco; Mark H Stoler; Mark Schiffman; Philip E Castle; Evan R Myers; David Chelmow; Abbe Herzig; Jane J Kim; Walter Kinney; W Lawson Herschel; Jeffrey Waldman
Journal:  J Low Genit Tract Dis       Date:  2012-07       Impact factor: 1.925

9.  The utility and management of vaginal cytology after treatment for endometrial cancer.

Authors:  Akiva P Novetsky; Lindsay M Kuroki; L Stewart Massad; Andrea R Hagemann; Premal H Thaker; Matthew A Powell; David G Mutch; Israel Zighelboim
Journal:  Obstet Gynecol       Date:  2013-01       Impact factor: 7.661

10.  Chronic disease as a barrier to breast and cervical cancer screening.

Authors:  C I Kiefe; E Funkhouser; M N Fouad; D S May
Journal:  J Gen Intern Med       Date:  1998-06       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.